云南高校图书馆联盟文献共享服务平台- PRAMIPEXOLE

PRAMIPEXOLE: 作品数：16被引量：39H指数：3; 导出分析报告; 相关领域：医药卫生更多>>; 相关作者：李超更多>>; 相关机构：山东大学南京工业大学更多>>; 相关期刊：《Acta Pharmacologica Sinica》《Pharmacology & Pharmacy》《Translational Neurodegeneration》《Advances in Parkinson's Disease》更多>>; 相关基金：国家自然科学基金北京市自然科学基金更多>>

Pramipexole in Treatment Resistant Depression: A Case Review: 《Pharmacology & Pharmacy》2023年第7期223-227,共5页Nada Abdallah Jeffrey Kahn; Pramipexole is a dopamine agonist used in the treatment of Parkinson’s disease and Restless legs syndrome. Although off-label, the use of Pramipexole as an adjunct therapy in treatment resistant depression has recent...; 关键词：PRAMIPEXOLE Treatment Resistant Depression Augmentation Dopamine Agonism Geriatric Psychiatry

Pramipexole inhibits astrocytic NLRP3 inflammasome activation via Drd3-dependent autophagy in a mouse model of Parkinson’s disease被引量：5: 《Acta Pharmacologica Sinica》2023年第1期32-43,共12页An-qi Dong Ya-ping Yang Shu-min Jiang Xiao-yu Yao Di Qi Cheng-jie Mao Xiao-yu Cheng Fen Wang Li-fang Hu Chun-feng Liu; This work was supported by grants from the National Natural Science Foundation of China (81671250,82071420,82101333,81870997,82171251);Jiangsu Provincial Key R&D Program (BE2018658);the Key Project of Natural Science Foundation of Jiangsu Provincial Higher Education Institutions (21KJA180003);the Priority Academic Program Development of Jiangsu Higher Education Institutions(PAPD).; Inflammation is one of the pathogenic processes in Parkinson’s disease(PD).Dopamine receptor agonist pramipexole(PPX)is extensively used for PD treatment in clinics.A number of studies show that PPX exerts neuroprote...; 关键词：Parkinson's disease neuroinflammation astrocytes NLRP3 inflammasome AUTOPHAGY dopamine D3 receptor

Pramipexole, a dopamine D3/D2 receptor-preferring agonist, attenuates reserpine-induced fibromyalgia-like model in mice被引量：3: 《Neural Regeneration Research》2022年第2期450-458,共9页Carlos Pereira Martins Rodrigo Sebben Paes Gabriela Mantovani Baldasso Eduarda Gomes Ferrarini Rahisa Scussel Rubya Pereira Zaccaron Ricardo Andrez Machado-de-Avila Paulo Cesar Lock Silveira Rafael Cypriano Dutra; supported by grants from Programa de Pos-graduacao em Neurociencias(PGN),Programa INCT-INOVAMED(grant No.465430/2014-7);Fundacao de Apoio à Pesquisa e Inovacao do Estado de Santa Catarina(FAPESC);Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(CAPES)。; Fibromyalgia(FM) is a complex pathology described as persistent hyperalgesia including somatic and mood dysfunctions, depression and anxiety. Although the etiology of FM is still unknown, a significant decrease in bio...; 关键词：DOPAMINE dopaminergic system FIBROMYALGIA HYPERALGESIA pain PRAMIPEXOLE RESERPINE

Problems Associated with Non-Ergot Dopamine Agonist Maintenance Therapy in Patients with Advanced Parkinson’s Disease: 《Advances in Parkinson's Disease》2019年第3期35-41,共7页Makoto Shiraishi Futaba Maki Naoshi Sasaki Yasuhiro Hasegawa; Non-ergot dopamine agonists have become popular for treating motor complications associated with long-term use of levodopa-containing drugs. We conducted a retrospective study in which we identified clinical problems ...; 关键词：Parkinson’s Disease Non-Ergot Dopamine Agonist WEARING-OFF ROPINIROLE PRAMIPEXOLE

Pathological Gambling after Administration of Pramipexole: 《Case Reports in Clinical Medicine》2018年第5期349-351,共3页Konstantinos Kontoangelos Marina Ecomomou Charalambos Papageorgiou; Parkinson’s disease is a common condition usually treated by dopaminergic agents and many behavioral abnormalities such as impulse control disorders (ICD) are connected with that usage. Pathological gambling, a form ...; 关键词：PRAMIPEXOLE PATHOLOGICAL GAMBLING SIDE Effects PARKINSON Disease

Reassessment subacute MPTP-treated mice model of Parkinson disease: 《中国药理学与毒理学杂志》2017年第10期1024-1025,共2页Lu WEN Yu-he YUAN Nai-hong CHEN; supported by National Natural Science Foundation of China(81373997,U1402221,81573640 and 81603316);Beijing Natural Science Foundation(7161011);Beijing Key Laboratory of New Drug Mechanisms and Pharmacological Evaluation Study(BZ0150);CAMS Innovation Fund for Medical Sciences(CIFMS)(2016-I2M-1-004);Key Research and Development Project of Hunan Province(2015SK2029-1);Scientific Research Foundation of the Higher Education Institutions of Hunan Province(15K091); OBJECTIVE(1) To estimate the value of the subacute MPTP mouse model in aspects of behavioral performance,biochemical changes and pathological abnormalities.(2) To find effective positive drugs.METHODS Male C57 BL/6 mi...; 关键词：subacute MPTP model Parkinson disease SELEGILINE PRAMIPEXOLE Α-SYNUCLEIN

Reassessment of subacute MPTP-treated mice as animal model of Parkinson＇s disease被引量：25: 《Acta Pharmacologica Sinica》2017年第10期1317-1328,共12页Qiu-shuang ZHANG Yang HENG Zheng MOU Ju-yang HUANG Yu-he YUAN Nai-hong CHEN; 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine （MPTP） mouse model remains the most commonly used animal model of Parkinson＇s disease （PD）. There are three MPTP-treatment schemes： acute, subacute and chronic. Consi...; 关键词：Parkinson＇s disease MPTP model SELEGILINE PRAMIPEXOLE medopar behavioral compensation ASTROCYTES Α-SYNUCLEIN blood brain＂barrier myelin sheath

Alpha-Dihydroergocryptine vs. Pramipexole as Adjunct Symptomatic Treatment of Idiopathic Parkinson’s: 《Advances in Parkinson's Disease》2015年第1期1-8,共8页Ulises Rodríguez Ortiz Daniel San- Juan Francesco Scarci; A randomized, double blind, and active reference-controlled study was carried out among 116 patients suffering from idiopathic Parkinson’s disease (PD). The aim of the study was to compare the safety and efficacy of ...; 关键词：ADJUNCT Symptomatic Therapy Alpha-Dihydroergocryptine PRAMIPEXOLE IDIOPATHIC Parkinson’s Disease Motor Complications UPDRS

Self-Reported Adherence after Overnight Switching from Immediate- to Extended-Release Pramipexole in Parkinson’s Disease: 《Advances in Parkinson's Disease》2015年第1期13-19,共7页Mutsumi Iijima Mikio Osawa Kenji Maruyama Shinichiro Uchiyama Kazuo Kitagawa; Background: Drug adherence decreased in patients with Parkinson’ s disease (PD) because of taking many different types of drugs. We evaluated drug adherence after switching from immediate-release (IR) to once-daily e...; 关键词：Parkinson’s Disease Timing ADHERENCE PRAMIPEXOLE EXTENDED-RELEASE Immediate-Release Motor Function

Efficacy of Pramipexole for Treatment of Apathy in Parkinson’s Disease被引量：3: 《International Journal of Clinical Medicine》2014年第15期885-889,共5页Hiroaki Oguro Katsuhiko Kadota Masaki Ishihara Kazunori Okada Shuhei Yamaguchi; Background: Apathy occurs frequently in patients with Parkinson’s disease (PD), and has a negative impact on activities of daily living through loss of motivation. Pramipexole (PPX), which shows preferential affinity...; 关键词：PRAMIPEXOLE APATHY Parkinson’s disease DEPRESSION UPDRS

PRAMIPEXOLE